146 related articles for article (PubMed ID: 1970933)
1. [Involvements of neuropeptides in pentylenetetrazol-induced convulsion in rats and effects of TRH and ceruletide on the convulsion].
Hashiguchi S; Masuda T; Fujimoto H; Kawai H; Saito S
No To Shinkei; 1990 Jan; 42(1):73-8. PubMed ID: 1970933
[TBL] [Abstract][Full Text] [Related]
2. [Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
Masuda T; Fujimoto H; Kawai H; Saito S
Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):362-74. PubMed ID: 2842204
[TBL] [Abstract][Full Text] [Related]
3. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
[TBL] [Abstract][Full Text] [Related]
4. [Effect of amygdaloid kindling on thyrotropin-releasing hormone, somatostatin, cholecystokinin and substance P contents of the amygdala/piriform cortex and hippocampus of rats].
Kajita S; Yamashita K; Nakashima M; Otsuki S; Ogawa N; Sato M
No To Shinkei; 1988 Jun; 40(6):525-30. PubMed ID: 2465012
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain before and after pentylenetetrazol-induced convulsion.
Pitkänen A; Sirviö J; Jolkkonen J; Riekkinen P
Neuropeptides; 1986 Jan; 7(1):63-71. PubMed ID: 2869441
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Quirion R; Welner S; Gauthier S; Bédard P
Synapse; 1987; 1(6):559-66. PubMed ID: 2843996
[TBL] [Abstract][Full Text] [Related]
7. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
Ahmed MM; Arif M; Chikuma T; Kato T
Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312
[TBL] [Abstract][Full Text] [Related]
8. Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptors.
Toledano A; Rodríguez-Arellano JJ; Gómez de Segura IA; De Miguel E; Martínez-Rodríguez R
Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1145-58. PubMed ID: 8997519
[TBL] [Abstract][Full Text] [Related]
9. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
10. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
Donato di Paola E; Cusack B; Yamada M; Richelson E
J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain.
Stenfors C; Theodorsson E; Mathé AA
J Neurosci Res; 1989 Nov; 24(3):445-50. PubMed ID: 2480456
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptides and electroconvulsive treatment.
Mathé AA
J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterization of somatostatin receptors in rat brain.
Sato H; Ota Z; Ogawa N
Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):203-18. PubMed ID: 2574901
[TBL] [Abstract][Full Text] [Related]
15. The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats.
Hernandez DE; Nemeroff CB; Orlando RC; Prange AJ
J Neurosci Res; 1983; 9(2):145-57. PubMed ID: 6302295
[TBL] [Abstract][Full Text] [Related]
16. [Effect of intracerebroventricular neurotensin injection on blood pressure in rat].
Zhang XH; Yin GX; Ni H
Sheng Li Xue Bao; 1999 Apr; 51(2):140-6. PubMed ID: 11499007
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
18. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
Levant B; Nemeroff CB
J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198
[TBL] [Abstract][Full Text] [Related]
19. Increase in dopamine metabolites in rat brain by neurotensin.
Widerlöv E; Kilts CD; Mailman RB; Nemeroff CB; Mc Cown TJ; Prange AJ; Breese GR
J Pharmacol Exp Ther; 1982 Oct; 223(1):1-6. PubMed ID: 6811728
[TBL] [Abstract][Full Text] [Related]
20. [Effect of intracerebral injections of somatostatin and neurotensin on motor functions in seizure].
Shandra OA; Hodlevskyĭ LS; Vastíanov RS; Panenko AV
Fiziol Zh (1978); 1993; 39(5-6):76-82. PubMed ID: 7913897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
